Aptevo Therapeutics

APVO

Börsenwert 2,62 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Sessa Capital New York	6,9 Mio. $	–	–	–
2	2 Dimensional Fund Advisors Austin, Texas	4,65 Mio. $	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	3,14 Mio. $	–	–	–
4	4 Renaissance Technologies New York	1,82 Mio. $	–	–	–
5	5 BlackRock New York	1,49 Mio. $	–	–	–
6	6 D.E. Shaw & Co New York	1,38 Mio. $	–	–	–
7	CL 7 CSS LLC Chicago, Illinois	939.000 $	–	–	–
8	8 Millennium Management New York	911.000 $	–	–	–
9	9 Victory Capital Management San Antonio, Texas	827.000 $	–	–	–
10	10 Precept Management Dallas, Texas	806.000 $	–	–	–
11	11 First Sabrepoint Capital Management Dallas, Texas	721.000 $	–	–	–
12	12 Virtu Financial New York	690.000 $	–	–	–
13	13 Oxford Asset Management Oxford, United Kingdom	599.000 $	–	–	–
14	14 Fidelity Investments Boston, Massachusetts	596.000 $	–	–	–
15	15 AQR Arbitrage Greenwich, Connecticut	562.000 $	–	–	–
16	16 Geode Capital Management Boston, Massachusetts	408.000 $	–	–	–
17	17 Spark Investment Management New York	300.000 $	–	–	–
18	18 Acadian Asset Management Boston, Massachusetts	287.000 $	–	–	–
19	ARTA 19 A.R.T. Advisors New York	251.000 $	–	–	–
20	20 JP Morgan Chase New York	241.000 $	–	–	–
21	21 Northern Trust Chicago, Illinois	235.000 $	–	–	–
22	22 Bridgeway Capital Management Houston, Texas	194.000 $	–	–	–
23	23 UBS Group Zurich, Switzerland	193.000 $	–	–	–
24	24 OMERS Administration Corp Toronto, Ontario, Canada	159.000 $	–	–	–
25	25 Morgan Stanley New York	116.000 $	–	–	–

Aptevo Therapeutics APVO Börsenwert 2,62 Mio. $

Aptevo Therapeutics

APVO

Börsenwert 2,62 Mio. $